Skip to main content
. 2021 Jun 8;12:3452. doi: 10.1038/s41467-021-23687-8

Fig. 8. Tau biochemistry findings in representative progressive apraxia of speech patients with either corticobasal degeneration (CBD) or progressive supranuclear palsy (PSP) pathology, and controls.

Fig. 8

Western blot findings in representative CBD (top panel) and PSP (bottom panel) cases. Apraxia of speech (AOS) denotes the progressive apraxia of speech cases; C1/2 denotes the matched controls; and CP-A denotes pure controls with no co-pathologies. This experiment was replicated independently in eight CBD cases and seven PSP cases with similar results. Two representative cases for each pathology are shown in this figure. The full scan images are provided in Supplementary Fig. 10.